Open access
Open access
Powered by Google Translator Translator

Family Medicine

The COVID generation: how is the pandemic affecting kids’ brains?

13 Jan, 2022 | 08:53h | UTC

The COVID generation: how is the pandemic affecting kids’ brains? – Nature

 


A clinical case definition of post-COVID-19 condition by a Delphi consensus.

13 Jan, 2022 | 08:45h | UTC

A clinical case definition of post-COVID-19 condition by a Delphi consensus – The Lancet Infectious Diseases

 

Commentary on Twitter

 


Review: Diagnosis and treatment of sexually transmitted infections.

13 Jan, 2022 | 08:38h | UTC

Diagnosis and Treatment of Sexually Transmitted Infections: A Review – JAMA (free for a limited period)

 


The year in cardiovascular medicine 2021: diabetes and metabolic disorders.

13 Jan, 2022 | 08:33h | UTC

The year in cardiovascular medicine 2021: diabetes and metabolic disorders – European Heart Journal

 


The year in cardiovascular medicine 2021: dyslipidemia.

13 Jan, 2022 | 08:30h | UTC

The year in cardiovascular medicine 2021: dyslipidemia – European Heart Journal

 


M-A: Intermittent Fasting and Obesity-Related Health Outcomes.

13 Jan, 2022 | 08:22h | UTC

Intermittent Fasting and Obesity-Related Health Outcomes: An Umbrella Review of Meta-analyses of Randomized Clinical Trials – JAMA Network Open

 


Cohort Study: In preterm premature rupture of membranes at 24-31 weeks, antibiotic prophylaxis based on third-generation cephalosporin may be associated with improved perinatal outcomes compared to amoxicillin.

13 Jan, 2022 | 08:10h | UTC

Antibiotic prophylaxis in preterm premature rupture of membranes at 24-31 weeks’ gestation: perinatal and 2-year outcomes in the EPIPAGE-2 cohort – BJOG (link to abstract – $ for full-text)

 


International study identifies predictors of severe outcomes in children with COVID-19.

12 Jan, 2022 | 09:05h | UTC

News Release: International study identifies predictors of severe outcomes in children with COVID-19 – University of Calgary

Original Study: Outcomes of SARS-CoV-2–Positive Youths Tested in Emergency Departments: The Global PERN–COVID-19 Study – JAMA Network Open

 


Statement on potential drug-drug interactions between Ritonavir-boosted Nirmatrelvir (Paxlovid) and concomitant medications; antiarrhythmics, oral anticoagulants, immunosuppressants, anticonvulsants, antineoplastics, and neuropsychiatric drugs are among the drugs of concern.

12 Jan, 2022 | 09:09h | UTC

The COVID-19 Treatment Guidelines Panel’s Statement on Potential Drug-Drug Interactions Between Ritonavir-Boosted Nirmatrelvir (Paxlovid) and Concomitant Medications – NIH COVID-19 Treatment Guidelines Panel

Commentaries:

Pfizer antiviral pills may be risky with other medications – NBC News

The New COVID-19 Pill, Paxlovid, Interacts with Many Medications: Cardiac Patients Take Note – The Skeptical Cardiologist

See also: What’s New in the Guidelines – NIH COVID-19 Treatment Guidelines

 


Podcast: Long COVID Pearls.

12 Jan, 2022 | 09:04h | UTC

#315 Long COVID with Dr. Monica Verduzco-Gutierrez – The Curbsiders

 


RCT: Endoscopic sinus surgery with medical therapy vs. medical therapy alone for chronic rhinosinusitis with nasal polyps.

12 Jan, 2022 | 08:51h | UTC

Endoscopic sinus surgery with medical therapy versus medical therapy for chronic rhinosinusitis with nasal polyps: a multicentre, randomised, controlled trial – The Lancet Respiratory Medicine (link to abstract – $ for full-text)

 

Commentary on Twitter

 


RCT: Among patients younger than 21 years of age with provoked thromboembolism, anticoagulation for 6 weeks was non-inferior vs. 12 weeks on the risk of recurrence and bleeding events.

12 Jan, 2022 | 08:53h | UTC

Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism: The Kids-DOTT Randomized Clinical Trial – JAMA (free for a limited period)

Editorial: Duration of Anticoagulant Treatment for Acute Provoked Venous Thromboembolism in Pediatric Patients – JAMA (free for a limited period)

 


Cohort Study: Higher consumption of olive oil linked to lower risk of cardiovascular, cancer, and all-cause mortality.

12 Jan, 2022 | 08:41h | UTC

Consumption of Olive Oil and Risk of Total and Cause-Specific Mortality Among U.S. Adults – Journal of the American College of Cardiology (link to abstract – $ for full-text)

Commentaries:

Higher olive oil intake associated with lower risk of CVD mortality – American College of Cardiology

Higher Olive Oil Intake May Be Associated With Lower Risk of CVD Mortality – American College of Cardiology

 


Consequences of a diagnostic label: A systematic scoping review and thematic framework.

12 Jan, 2022 | 08:37h | UTC

Consequences of a Diagnostic Label: A Systematic Scoping Review and Thematic Framework – Frontiers in Public Health

 


AHA Scientific Statement: Comprehensive management of cardiovascular risk factors for adults with Type 2 Diabetes.

11 Jan, 2022 | 02:40h | UTC

Comprehensive Management of Cardiovascular Risk Factors for Adults With Type 2 Diabetes: A Scientific Statement From the American Heart Association – Circulation

News Release: Fewer than 1 in 5 adults with Type 2 diabetes in the U.S. are meeting optimal heart health targets – American Heart Association

 


Medical Decisions: Some are Easy and Some Not So Much.

11 Jan, 2022 | 02:31h | UTC

Medical Decisions: Some are Easy and Some Not So Much – Stop and Think blog, by John Mandrola

 

Commentary on Twitter

 


Systematic Review: The effectiveness and safety of treatments for recurrent vulvovaginal candidiasis.

11 Jan, 2022 | 02:24h | UTC

Treatment for recurrent vulvovaginal candidiasis (thrush) – Cochrane Library

Summary: The effectiveness and safety of treatments for recurrent vulvovaginal candidiasis (thrush) – Cochrane Library

 


The ‘Ten Commandments’ of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.

11 Jan, 2022 | 02:20h | UTC

The ‘Ten Commandments’ of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure – European Heart Journal

Original Guideline: #ESCCongress – 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure – SGLT2 inhibitors are now recommended for patients with heart failure with reduced ejection fraction regardless of the presence of diabetes.

Related:

NICE Guideline | Acute heart failure: diagnosis and management.

The ‘ten commandments’ for the 2021 ESC Guidelines on CVD prevention.

 


M-A: Fecal immunochemical test to triage patients with possible colorectal cancer symptoms.

11 Jan, 2022 | 02:18h | UTC

Faecal immunochemical test to triage patients with possible colorectal cancer symptoms: meta-analysis – British Journal of Surgery

Commentary: Guest Plain English summary: Worried about symptoms of bowel cancer? A simple stool test may help. – Cutting Edge

 

Commentary on Twitter

 


Cohort Study: Ciprofloxacin exposure during pregnancy was not associated with miscarriage or major malformations in a nationwide study from Denmark.

11 Jan, 2022 | 02:08h | UTC

Ciprofloxacin exposure and adverse pregnancy outcomes: a Danish nationwide cohort study – BJOG (link to abstract – $ for full-text)

 


Cohort study: Among health care workers previously vaccinated with 2 doses of the Pfizer-BioNTech vaccine, receiving a third dose was associated with reduced risk of SARS-CoV-2 infection.

11 Jan, 2022 | 01:35h | UTC

Association of a Third Dose of BNT162b2 Vaccine With Incidence of SARS-CoV-2 Infection Among Health Care Workers in Israel – JAMA

Editorial: Booster Vaccination to Reduce SARS-CoV-2 Transmission and Infection – JAMA

 


Review: Rapid diagnostic testing for SARS-CoV-2.

11 Jan, 2022 | 01:34h | UTC

Rapid Diagnostic Testing for SARS-CoV-2 – New England Journal of Medicine

 


M-A: Fatigue and cognitive impairment in Post-COVID-19 Syndrome.

11 Jan, 2022 | 01:28h | UTC

Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis – Brain, Behavior, and Immunity

 


CDC Report: COVID-19 vaccine safety in children aged 5–11 Years.

9 Jan, 2022 | 01:09h | UTC

COVID-19 Vaccine Safety in Children Aged 5–11 Years — United States, November 3–December 19, 2021 – CDC Morbidity and Mortality Weekly Report

Commentary: COVID-19 vaccine appears safe in children aged 5–11 Years – News Medical

 

Commentary on Twitter

 


New CDC Guidance shortens isolation and quarantine period for Covid-19; patients that tested positive should isolate for 5 days and, if asymptomatic after this period, can leave isolation if they can continue to mask for 5 days to minimize the risk of infecting others.

9 Jan, 2022 | 01:13h | UTC

CDC Updates and Shortens Recommended Isolation and Quarantine Period for General Population – Centers for Disease Control and Prevention

See also: Quarantine and Isolation – Centers for Disease Control and Prevention

Commentaries:

Facing criticism, CDC updates Covid-19 isolation recommendations with guidance on testing – CNN

CDC posts rationale for shorter isolation, quarantine – Associated Press

Covid-19: CDC shortens isolation period as US cases hit record high – The BMJ

Shortened CDC COVID isolation guide draws sharply mixed reviews – CIDRAP

New CDC isolation guidelines raise concerns among health experts – NPR

CDC Reduces Recommended Isolation Time for People With COVID-19 – HealthDay

COVID isolation and quarantine period for general population shortened by CDC – News Medical

CDC shortens recommended Covid-19 isolation and quarantine time – CNN

CDC cuts the recommended isolation and quarantine periods for coronavirus infections – NPR

US officials recommend shorter COVID isolation, quarantine – Associated Press

See new recommendations from other countries:

France cuts isolation times and plans crackdown on unvaccinated amid record surge in Covid cases – CNN

Covid: Self-isolation cut from 10 days to seven with negative tests – BBC

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.